Andrew Galler
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
27
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Maintains: Overweight | $80 → $74 | $31.17 | +137.41% | 11 | Oct 11, 2024 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $11.33 | +32.39% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $17.83 | +0.95% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $20.06 | +84.45% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $38.44 | +45.68% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $9.37 | +92.10% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $40.39 | +33.70% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $58.47 | -14.49% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $3.02 | +1,356.95% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $53.54 | +467.80% | 1 | Nov 9, 2021 |
Immunocore Holdings
Oct 11, 2024
Maintains: Overweight
Price Target: $80 → $74
Current: $31.17
Upside: +137.41%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $11.33
Upside: +32.39%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $17.83
Upside: +0.95%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $20.06
Upside: +84.45%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $38.44
Upside: +45.68%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $9.37
Upside: +92.10%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $40.39
Upside: +33.70%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $58.47
Upside: -14.49%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $3.02
Upside: +1,356.95%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $53.54
Upside: +467.80%